Drug Utilization Patterns in Patients with Diabetes Initiating Sodium Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Japan: A Multi-Database Study (2014-2017).
Yuichiro ItoJames Van SchyndleTakuya NishimuraToshifumi SugitaniTomomi KimuraPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Astellas Pharma Inc., Tokyo, Japan.
Keyphrases